Found: 15
Select item for more details and to access through your institution.
Extended‐release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 861, doi. 10.1111/dom.14284
- By:
- Publication type:
- Article
Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 3049, doi. 10.2147/DMSO.S381652
- By:
- Publication type:
- Article
Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy.
- Published in:
- International Journal of Pediatric Endocrinology, 2013, v. 2013, n. 1, p. 1, doi. 10.1186/1687-9856-2013-20
- By:
- Publication type:
- Article
Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2002, v. 18, n. 2, p. 127, doi. 10.1002/dmrr.264
- By:
- Publication type:
- Article
Poster 345 Safety and Efficacy of Oxymorphone Extended Release for Chronic Low Back Pain in Patients With Comorbidities
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Poster 339 Dosage Titration of Oxymorphone Extended Release for Relief of Chronic Low Back Pain in Patients With Comorbidities
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Poster 302 Effectiveness and Safety of a Lidocaine 5% Patch as Add-on Treatment in Patients With Allodynia Caused by Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Poster 345 Safety and Efficacy of Oxymorphone Extended Release for Chronic Low Back Pain in Patients With Comorbidities.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2011, v. 3, p. S293, doi. 10.1016/j.pmrj.2011.08.373
- By:
- Publication type:
- Article
Poster 339 Dosage Titration of Oxymorphone Extended Release for Relief of Chronic Low Back Pain in Patients With Comorbidities.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2011, v. 3, p. S290, doi. 10.1016/j.pmrj.2011.08.367
- By:
- Publication type:
- Article
Poster 302 Effectiveness and Safety of a Lidocaine 5% Patch as Add‐on Treatment in Patients With Allodynia Caused by Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2011, v. 3, p. S276, doi. 10.1016/j.pmrj.2011.08.330
- By:
- Publication type:
- Article
Poster 345 Safety and Efficacy of Oxymorphone Extended Release for Chronic Low Back Pain in Patients With Comorbidities.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Poster 339 Dosage Titration of Oxymorphone Extended Release for Relief of Chronic Low Back Pain in Patients With Comorbidities.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Poster 302 Effectiveness and Safety of a Lidocaine 5% Patch as Add‐on Treatment in Patients With Allodynia Caused by Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Poster 253: Challenges to Successful Titration of Chronic Low Back Pain Patients to Oxymorphone Extended Release.
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Poster 253: Challenges to Successful Titration of Chronic Low Back Pain Patients to Oxymorphone Extended Release
- Published in:
- 2009
- By:
- Publication type:
- Abstract